Skip to main content

Optimizing Surgical Outcomes

  • Chapter
  • First Online:
Skin Cancer Management

Abstract

To optimize outcomes associated with cutaneous procedures the surgeon must consider multiple factors. Many of these factors should be addressed prior to the start of surgery and others require attention during or after the procedure. Recognition of these factors can aid in the meticulous planning and attention to detail necessary to obtain the best outcome following surgical treatment of skin cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, et al. AAD/ACMS/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67(4):531–50. https://doi.org/10.1016/j.jaad.2012.06.009.

    Article  PubMed  Google Scholar 

  2. Chong T, Tristani-Firouzi P, Bowen GM, Hadley LML, Duffy KL. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. Dermatol Surg. 2015;8:889–95. (PMID: 2606619).

    Google Scholar 

  3. Brown DG, Wilkerson EC, Love WE. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons. J Am Acad Dermatol. 2015;72(3):524–34.

    CAS  PubMed  Google Scholar 

  4. Plovanich M, Mostaghimi A. Novel oral anticoagulants: what dermatologists need to know. J Am Acad Dermatol. 2015;72:535–40.

    PubMed  Google Scholar 

  5. Carpenter E, Singh D, Dietrich E, Gums J. Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation. Ther Adv Saf. 2019;10 https://doi.org/10.1177/2042098619888133.

  6. Pollack CV, Reilley PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, et al. Idarucizumab for dabigatran reversal-full cohort analysys. N Engl J Med. 2017;377:431–41.

    CAS  PubMed  Google Scholar 

  7. Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg. 2004;30:1091–4.

    PubMed  Google Scholar 

  8. Eilers RE Jr, Goldenberg A, Cowan NL, Basu P, Brian Jiang SI. A retrospective assessment of postoperative bleeding complications in anticoagulated patients following mohs micrographic surgery. Dermatol Surg. 2018;44(4):504–11.

    CAS  PubMed  Google Scholar 

  9. Chang TW, Arpey CJ. Complications with new oral anticoagulants dabigatran and rivaroxaban in cutaneous surgery. Dermatol Surg. 2015;41:784–93.

    CAS  PubMed  Google Scholar 

  10. Antia C, Hone N. Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: a retrospective study. J Am Acad Dermatol. 2017;5:967–8.

    Google Scholar 

  11. Schanbacker CF, Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg. 2000;26:785–9.

    Google Scholar 

  12. Alam M, Goldberg LH. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg. 2002;28(11):28992–8.

    Google Scholar 

  13. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol. 2003;48:233–7.

    PubMed  Google Scholar 

  14. Khalifeh MR, Redett RJ. The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations. Plast Reconstr Surg. 2006;118:110e–7e.

    PubMed  Google Scholar 

  15. Chang LK, Whitaker DC. The impact of herbal medicines on dermatologic surgery. Dermatol Surg. 2001;27:759–7.

    CAS  PubMed  Google Scholar 

  16. Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary supplement use among US adults from 1999 to 2012. JAMA. 2016;316(14):1464–74.

    PubMed  PubMed Central  Google Scholar 

  17. Timbo BB, Ross MP, McCarthy PV, et al. Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc. 2006;106:1966–74.

    CAS  PubMed  Google Scholar 

  18. Cox AC, Rao GH, Gerrard JM, White JG. The influence of vitamin E quinone on platelet structure, function, and biochemistry. Blood. 1980;55:907–14.

    CAS  PubMed  Google Scholar 

  19. Ziv O, Ragni MV. Bleeding manifestations in males with von Willebrand disease. Haemophilia. 2004;10:162–8.

    CAS  PubMed  Google Scholar 

  20. Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993;123:893–8.

    CAS  PubMed  Google Scholar 

  21. Leonard AL, Hanke CW, Greist A. Perioperative management of von Willebrand disease in dermatologic surgery. Dermatol Surg. 2007;33:403–9.

    CAS  PubMed  Google Scholar 

  22. Nichols WC, Ginsburg D. Von Willebrand disease. Medicine (Baltimore). 1997;76:1–20.

    CAS  PubMed  Google Scholar 

  23. Bailey BJ, Johnson JT, Newlands SD. Head & neck surgery—otolaryngology. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 217.

    Google Scholar 

  24. Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative anti-inflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25:1566–91.

    CAS  PubMed  Google Scholar 

  25. Abdelmalek M, Spencer J. Retinoids and wound healing. Dermatol Surg. 2006;32:1219–30.

    CAS  PubMed  Google Scholar 

  26. Taniguchi Y, Shimizu Y, Inachi S, Shimizu M. Skin surgery in patients 90 years of age and over. Int J Dermatol. 1998;37:547–50.

    CAS  PubMed  Google Scholar 

  27. MacFarlane DF, Pustelny BL, Goldberg LH. An assessment of the suitability of Mohs micrographic surgery in patients aged 90 years and older. Dermatol Surg. 1998;23:389–92.

    Google Scholar 

  28. Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol. 1998;8:591–5.

    CAS  PubMed  Google Scholar 

  29. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70(2):252–89.

    PubMed  Google Scholar 

  30. Quinn RH, Murray JN, Pezold R, Sevarino KS, Members of the Writing and Voting Panels of the AUC for the Management of Patients with Orthopedic Implants Undergoing Dental Procedures. The American academy of orthopaedic surgeons appropriate use criteria for the management of patients with orthopaedic implants undergoing dental procedures. J Bone Joint Surg Am. 2017;99(2):161–3. https://doi.org/10.2106/JBJS.16.01107.

    Article  PubMed  Google Scholar 

  31. Lee MR, Paver R. Prophylactic antibiotics in dermatological surgery. Australas J Dermatol. 2016;57(2):83–91. https://doi.org/10.1111/ajd.12312.

    Article  PubMed  Google Scholar 

  32. Sheridan RL, Schulz JT, Weber JM, et al. Cutaneous herpetic infections complicating burns. Burns. 2000;26:621–4.

    CAS  PubMed  Google Scholar 

  33. Fidler PE, Mackool BT, Schoenfeld DA, et al. Incidence, outcome, and long-term consequences of herpes simplex virus type 1 reactivation presenting as a facial rash in intubated adult burn patients treated with acyclovir. J Trauma. 2002;53:86–9.

    PubMed  Google Scholar 

  34. Verrill PJ. Adverse reactions to local anaesthetics and vasoconstrictor drugs. Practitioner. 1975;214:380–7.

    CAS  PubMed  Google Scholar 

  35. Amsler E, Flahault A, Mathelier-Fusade P, Aractingi S. Evaluation of re-challenge in patients with suspected lidocaine allergy. Dermatology. 2004;208:109–11.

    CAS  PubMed  Google Scholar 

  36. Dire DJ, Hogan DE. Double-blinded comparison of diphenhydramine versus lidocaine as a local anesthetic. Ann Emerg Med. 1993;22:1419–22.

    CAS  PubMed  Google Scholar 

  37. Romano A, Gueant-Rodriguez RM, Viola M, Pettinato R, Gueant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.

    CAS  PubMed  Google Scholar 

  38. El-Gamal HM, Dufresne RG, Saddler K. Electrosurgery, pacemakers, and ICDs: a survey of precautions and complications experienced by cutaneous surgeons. Dermatol Surg. 2001;27:385–90.

    CAS  PubMed  Google Scholar 

  39. Lane JE, O’Brien EM, Kent DE. Optimization of thermocautery in excisional dermatologic surgery. Dermatol Surg. 2006;32:669–75.

    CAS  PubMed  Google Scholar 

  40. Haines RC Jr, Brooks LR. Office space planning and design for medical practices, part 1: an overview. J Med Pract Manage. 2003;18:244–9.

    PubMed  Google Scholar 

  41. Haines RC Jr, Griffin JK. Office space planning and design for medical practices: part 3, implementation, design, and construction. J Med Pract Manage. 2003;19:19–26.

    PubMed  Google Scholar 

  42. Lutz ME. Surgical pearl: curettage before cutaneous surgery to identify an unidentifiable biopsy site. J Am Acad Dermatol. 2002;46:591–3.

    PubMed  Google Scholar 

  43. Robbins P, Sarnoff DS. Where’s the spot? J Dermatol Surg Oncol. 1986;12:1251–2.

    Google Scholar 

  44. Futoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg. 1995;21:509–14.

    CAS  PubMed  Google Scholar 

  45. Whitaker DC, Grande DJ, Johnson SS. Wound infection rate in dermatologic surgery. J Dermatol Surg Oncol. 1988;14:525–8.

    CAS  PubMed  Google Scholar 

  46. Carmichael AJ, Flanagan PG, Holt PJA, Duerden BI. The occurrence of bacteraemia with skin surgery. Br J Dermatol. 1996;134:120–2.

    CAS  PubMed  Google Scholar 

  47. Mulberry G, Snyder AT, Heilman J, Pyrek J, Stahl J. Evaluation of a waterless, scrubless chlorhexidine gluconate/ethanol surgical scrub for antimicrobial efficacy. Am J Infect Control. 2001;29:377–82.

    Google Scholar 

  48. Gupta C, Czubatyj AM, Briski LE, Malani AK. Comparison of two alcohol-based surgical scrub solutions with an iodine-based scrub brush for presurgical antiseptic effectiveness in a community hospital. J Hosp Infect. 2007;65:65–71.

    CAS  PubMed  Google Scholar 

  49. Rhinehart BM, Murphy ME, Farley MF, Albertini JG. Sterile versus nonsterile gloves during Mohs micrographic surgery: infection rate is not affected. Dermatol Surg. 2006;32:170–6.

    CAS  PubMed  Google Scholar 

  50. Brewer JD, Gonzalez AB. Comparison of sterile vs nonsterile gloves in cutaneous surgery and common outpatient dental procedures. JAMA Dermatol. 2016;152(9):1008–14.

    PubMed  Google Scholar 

  51. Kupres K, Rasmussen SE, Albertini JG. Perforation rates for nonsterile examination gloves in routine dermatologic procedures. Dermatol Surg. 2002;28:388–9.

    PubMed  Google Scholar 

  52. Gross DJ, Jamison Y, Martin K, Fields M, Dinehart SM. Surgical glove perforation in dermatologic surgery. J Dermatol Surg Oncol. 1989;15:1226–8.

    CAS  PubMed  Google Scholar 

  53. Cohen MD, Do JT, Tahery DP, Moy RL. Efficacy of double gloving as a protection against blood exposure in dermatologic surgery. J Dermatol Surg Oncol. 1992;18:873–4.

    CAS  PubMed  Google Scholar 

  54. Larson MJ, Taylor RS. Monitoring vital signs during outpatient Mohs and post-Mohs reconstructive surgery performed under local anesthesia. Dermatol Surg. 2004;30(5):777–83.

    PubMed  Google Scholar 

  55. Chipev CC, Simon M. Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1. BMC Dermatol. 2002;2:13.

    PubMed  PubMed Central  Google Scholar 

  56. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment: a randomized controlled trial. JAMA. 1996;276:972–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amy S. Ross .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stasko, T., MacFarlane, D.F., Ross, A.S. (2021). Optimizing Surgical Outcomes. In: MacFarlane, D.F. (eds) Skin Cancer Management. Springer, Cham. https://doi.org/10.1007/978-3-030-50593-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-50593-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-50592-9

  • Online ISBN: 978-3-030-50593-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics